Trends in HPV and HPV Vaccine Awareness among Gay and Bisexual Males in the U.S
- PMID: 35455355
- PMCID: PMC9032332
- DOI: 10.3390/vaccines10040604
Trends in HPV and HPV Vaccine Awareness among Gay and Bisexual Males in the U.S
Abstract
Human papillomavirus (HPV) is the most common sexually transmitted infection in the United States (US). It is often discussed within the context of women's sexual health due to its association with cervical cancer. However, HPV is also associated with other cancers and conditions which affect men. Gay and bisexual males (GBM) in the US have higher risks of HPV infection and a higher incidence of HPV-associated anal cancer than heterosexual males. In addition, GBM in the US have a higher prevalence of some high-risk strains of HPV than in other regions. HPV vaccination is highly effective at preventing HPV-associated cancers and genital warts. Several resources have been directed towards improving HPV awareness in the US over the past couple of years to improve vaccination rates. Given the low rates of HPV vaccination among GBM in the US, this study aimed to assess the trends in HPV and HPV vaccine awareness using a nationally representative sample of GBM. We found an overall increase in HPV and HPV vaccine awareness between 2017 and 2020. However, the sociodemographic differences in awareness levels highlight the need for more interventions to improve vaccination rates, especially in this high-risk population.
Keywords: HPV; HPV awareness; HPV vaccine; HPV vaccine awareness; bisexual; gay.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Gay and Bisexual Men in the US Lack Basic Information About Anal Cancer.J Low Genit Tract Dis. 2021 Jan 1;25(1):48-52. doi: 10.1097/LGT.0000000000000571. J Low Genit Tract Dis. 2021. PMID: 32947485 Free PMC article.
-
Health beliefs and attitudes associated with HPV vaccine intention among young gay and bisexual men in the Southeastern United States.Vaccine. 2011 Oct 19;29(45):8060-5. doi: 10.1016/j.vaccine.2011.08.045. Epub 2011 Aug 22. Vaccine. 2011. PMID: 21864615
-
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.Lancet Infect Dis. 2022 Mar;22(3):413-425. doi: 10.1016/S1473-3099(21)00327-3. Epub 2021 Nov 12. Lancet Infect Dis. 2022. PMID: 34780705 Clinical Trial.
-
Human papillomavirus vaccination in males.Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S24-6. doi: 10.1016/j.ygyno.2007.07.075. Gynecol Oncol. 2007. PMID: 17938015 Review.
-
Prophylactic HPV vaccination: past, present, and future.Epidemiol Infect. 2016 Feb;144(3):449-68. doi: 10.1017/S0950268815002198. Epub 2015 Oct 2. Epidemiol Infect. 2016. PMID: 26429676 Review.
Cited by
-
HPV Vaccination Status in HIV-Negative MSM and Its Association with High-Risk HPV Detection Using HPV Serology and Anorectal Swabs.Vaccines (Basel). 2024 Oct 9;12(10):1154. doi: 10.3390/vaccines12101154. Vaccines (Basel). 2024. PMID: 39460321 Free PMC article.
-
Uptake and determinants of HPV vaccination in South Asia: a systematic review and meta-analysis.Front Public Health. 2024 Dec 11;12:1453704. doi: 10.3389/fpubh.2024.1453704. eCollection 2024. Front Public Health. 2024. PMID: 39722717 Free PMC article.
-
Social capital interventions for human papillomavirus (HPV) immunization and cervical cancer screening: A rapid review.Can Commun Dis Rep. 2024 Jul 24;50(7-8):260-273. doi: 10.14745/ccdr.v50i78a04. eCollection 2024 Jul-Aug. Can Commun Dis Rep. 2024. PMID: 39170590 Free PMC article.
-
Application of CRISPR-Cas System in Human Papillomavirus Detection Using Biosensor Devices and Point-of-Care Technologies.BME Front. 2025 Mar 19;6:0114. doi: 10.34133/bmef.0114. eCollection 2025. BME Front. 2025. PMID: 40110345 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention HPV Fact Sheet. [(accessed on 1 February 2022)]; Available online: https://www.cdc.gov/std/hpv/stdfact-hpv.htm.
-
- McQuillan G., Kruszon-Moran D., Markowitz L.E., Unger E.R., Paulose-Ram R. Prevalence of HPV in Adults Aged 18–69: United States, 2011–2014. NCHS Data Br. 2017, 280. [(accessed on 1 February 2022)]; Available online: https://www.cdc.gov/nchs/products/databriefs/db280.htm. - PubMed
-
- Saraiya M., Unger E.R., Thompson T.D., Lynch C.F., Hernandez B.Y., Lyu C.W., Steinau M., Watson M., Wilkinson E.J., Hopenhayn C., et al. US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines. J. Natl. Cancer Inst. 2015;107:djv086. doi: 10.1093/jnci/djv086. - DOI - PMC - PubMed
-
- Food and Drug Administration News Release: FDA Approves Expanded Use of Gardasil 9 to Include Individuals 27 through 45 Years Old. [(accessed on 1 February 2022)]; Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-expande....
-
- Centers for Disease Control and Prevention Gay and Bisexual Men’s Health. [(accessed on 1 February 2022)]; Available online: https://www.cdc.gov/msmhealth/STD.htm.
LinkOut - more resources
Full Text Sources
Miscellaneous